Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Syncytial Virus Vaccines | 1 | 2025 | 70 | 0.890 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2025 | 345 | 0.730 |
Why?
|
Influenza Vaccines | 1 | 2025 | 481 | 0.670 |
Why?
|
Oxygen | 2 | 2015 | 556 | 0.660 |
Why?
|
Community Health Centers | 1 | 2019 | 39 | 0.640 |
Why?
|
Community Health Workers | 1 | 2019 | 65 | 0.610 |
Why?
|
Photoperiod | 1 | 2018 | 20 | 0.610 |
Why?
|
Influenza, Human | 1 | 2025 | 662 | 0.610 |
Why?
|
Periodicity | 1 | 2018 | 56 | 0.600 |
Why?
|
Transcriptional Activation | 2 | 2024 | 486 | 0.570 |
Why?
|
Photoplethysmography | 2 | 2015 | 5 | 0.570 |
Why?
|
Exercise | 2 | 2015 | 814 | 0.560 |
Why?
|
5-alpha Reductase Inhibitors | 1 | 2017 | 14 | 0.560 |
Why?
|
Decision Support Techniques | 2 | 2011 | 290 | 0.540 |
Why?
|
Computer Simulation | 1 | 2018 | 650 | 0.490 |
Why?
|
Models, Genetic | 1 | 2018 | 761 | 0.490 |
Why?
|
Stroke Volume | 2 | 2015 | 496 | 0.480 |
Why?
|
X-Box Binding Protein 1 | 3 | 2020 | 30 | 0.480 |
Why?
|
Pulse Wave Analysis | 1 | 2015 | 47 | 0.470 |
Why?
|
Uncertainty | 2 | 2012 | 99 | 0.460 |
Why?
|
Biomedical Engineering | 1 | 2014 | 27 | 0.450 |
Why?
|
Monitoring, Ambulatory | 2 | 2014 | 55 | 0.440 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 673 | 0.430 |
Why?
|
Primary Health Care | 1 | 2019 | 774 | 0.410 |
Why?
|
Health Information Management | 1 | 2012 | 6 | 0.410 |
Why?
|
Epidemics | 1 | 2012 | 54 | 0.390 |
Why?
|
Physiology | 1 | 2012 | 15 | 0.380 |
Why?
|
Games, Experimental | 1 | 2011 | 8 | 0.360 |
Why?
|
Health Policy | 1 | 2012 | 214 | 0.350 |
Why?
|
Wireless Technology | 1 | 2010 | 11 | 0.340 |
Why?
|
Depression | 1 | 2017 | 1232 | 0.310 |
Why?
|
Circadian Clocks | 2 | 2020 | 59 | 0.300 |
Why?
|
Circadian Rhythm | 4 | 2020 | 274 | 0.280 |
Why?
|
Tuberculosis | 1 | 2012 | 527 | 0.260 |
Why?
|
Patient Acceptance of Health Care | 1 | 2011 | 426 | 0.260 |
Why?
|
Liver | 4 | 2022 | 1748 | 0.240 |
Why?
|
Heart Failure | 3 | 2015 | 2298 | 0.230 |
Why?
|
Ribonucleotides | 1 | 2024 | 36 | 0.220 |
Why?
|
Homeostasis | 2 | 2020 | 705 | 0.220 |
Why?
|
RNA Stability | 1 | 2024 | 84 | 0.220 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2024 | 114 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2024 | 210 | 0.210 |
Why?
|
Gene Expression Regulation | 4 | 2020 | 2527 | 0.200 |
Why?
|
Biological Transport | 2 | 2015 | 355 | 0.200 |
Why?
|
Fibroblasts | 2 | 2024 | 887 | 0.200 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2023 | 139 | 0.190 |
Why?
|
Prostatic Neoplasms | 1 | 2011 | 1550 | 0.190 |
Why?
|
Breast Neoplasms | 2 | 2024 | 2520 | 0.190 |
Why?
|
Humans | 34 | 2025 | 125295 | 0.190 |
Why?
|
Transcription, Genetic | 4 | 2020 | 1708 | 0.180 |
Why?
|
Membrane Fluidity | 1 | 2020 | 18 | 0.180 |
Why?
|
Cyclohexanones | 1 | 2020 | 17 | 0.180 |
Why?
|
Nuclear Receptor Coactivator 3 | 1 | 2023 | 348 | 0.180 |
Why?
|
HIV Infections | 1 | 2012 | 1896 | 0.180 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 875 | 0.180 |
Why?
|
Phospholipids | 1 | 2020 | 105 | 0.170 |
Why?
|
Ultradian Rhythm | 1 | 2020 | 2 | 0.170 |
Why?
|
Mice | 10 | 2024 | 17754 | 0.170 |
Why?
|
Biological Clocks | 1 | 2020 | 28 | 0.160 |
Why?
|
Receptors, Adrenergic, beta | 1 | 2020 | 61 | 0.160 |
Why?
|
Ventricular Remodeling | 1 | 2020 | 184 | 0.160 |
Why?
|
Receptors, Steroid | 1 | 2020 | 273 | 0.160 |
Why?
|
Pyridines | 1 | 2020 | 234 | 0.160 |
Why?
|
Lipid Metabolism | 1 | 2022 | 356 | 0.160 |
Why?
|
Myocardium | 2 | 2024 | 1022 | 0.160 |
Why?
|
Oxidative Stress | 1 | 2024 | 818 | 0.150 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 276 | 0.150 |
Why?
|
Animals | 12 | 2024 | 34320 | 0.140 |
Why?
|
Unfolded Protein Response | 1 | 2017 | 62 | 0.140 |
Why?
|
Oxidoreductases | 1 | 2017 | 92 | 0.140 |
Why?
|
Male | 14 | 2025 | 61527 | 0.130 |
Why?
|
Self-Injurious Behavior | 1 | 2017 | 64 | 0.130 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2017 | 120 | 0.130 |
Why?
|
Organ Specificity | 2 | 2020 | 426 | 0.130 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 2015 | 12 | 0.120 |
Why?
|
Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2015 | 21 | 0.120 |
Why?
|
Non-alcoholic Fatty Liver Disease | 1 | 2020 | 403 | 0.120 |
Why?
|
Suicide | 1 | 2017 | 179 | 0.120 |
Why?
|
History, 20th Century | 2 | 2014 | 383 | 0.120 |
Why?
|
Healthy Volunteers | 1 | 2015 | 134 | 0.110 |
Why?
|
Portraits as Topic | 1 | 2014 | 3 | 0.110 |
Why?
|
Disease Management | 2 | 2015 | 530 | 0.110 |
Why?
|
Signal Transduction | 2 | 2024 | 4596 | 0.110 |
Why?
|
Vascular Diseases | 1 | 2015 | 155 | 0.110 |
Why?
|
Ethics, Medical | 2 | 1987 | 396 | 0.110 |
Why?
|
Aged | 5 | 2025 | 19704 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 1 | 2015 | 172 | 0.100 |
Why?
|
Decision Theory | 1 | 2012 | 2 | 0.100 |
Why?
|
History, 21st Century | 1 | 2014 | 267 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 377 | 0.100 |
Why?
|
Myocardial Infarction | 1 | 2020 | 1042 | 0.100 |
Why?
|
Heart Rate | 2 | 2015 | 582 | 0.100 |
Why?
|
Policy Making | 1 | 2012 | 59 | 0.100 |
Why?
|
Self Care | 1 | 2014 | 212 | 0.100 |
Why?
|
Attitude to Health | 1 | 2014 | 256 | 0.100 |
Why?
|
Mice, Knockout | 4 | 2023 | 3757 | 0.100 |
Why?
|
Chromatin | 1 | 2015 | 579 | 0.100 |
Why?
|
Oxyhemoglobins | 1 | 2012 | 24 | 0.090 |
Why?
|
Algorithms | 1 | 2018 | 1633 | 0.090 |
Why?
|
Ambulatory Care | 2 | 1997 | 391 | 0.090 |
Why?
|
Middle Aged | 4 | 2025 | 26726 | 0.090 |
Why?
|
Glucose | 1 | 2015 | 878 | 0.090 |
Why?
|
Computers | 1 | 2011 | 68 | 0.090 |
Why?
|
Fibrosis | 2 | 2024 | 442 | 0.090 |
Why?
|
Validation Studies as Topic | 1 | 2010 | 13 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2012 | 364 | 0.090 |
Why?
|
Hemoglobins | 1 | 2012 | 312 | 0.080 |
Why?
|
Pericarditis | 1 | 1990 | 42 | 0.080 |
Why?
|
Cardiac Output | 2 | 2010 | 170 | 0.080 |
Why?
|
Focus Groups | 1 | 2011 | 191 | 0.080 |
Why?
|
Computers, Handheld | 1 | 2010 | 33 | 0.080 |
Why?
|
Physicians | 2 | 1987 | 586 | 0.080 |
Why?
|
Female | 7 | 2025 | 66789 | 0.080 |
Why?
|
Burns | 2 | 1987 | 77 | 0.080 |
Why?
|
Health Education | 1 | 2011 | 221 | 0.080 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 1990 | 236 | 0.080 |
Why?
|
Reflex, Pupillary | 1 | 1989 | 15 | 0.080 |
Why?
|
Pellagra | 1 | 1988 | 1 | 0.080 |
Why?
|
Probability | 1 | 2009 | 318 | 0.070 |
Why?
|
Pupil | 1 | 1989 | 71 | 0.070 |
Why?
|
Global Health | 1 | 2012 | 570 | 0.070 |
Why?
|
Hospitals, Veterans | 1 | 1989 | 357 | 0.070 |
Why?
|
Time Factors | 3 | 2020 | 6307 | 0.070 |
Why?
|
Adult | 10 | 2015 | 29514 | 0.060 |
Why?
|
Pelvic Inflammatory Disease | 1 | 1986 | 3 | 0.060 |
Why?
|
Gas Gangrene | 1 | 1986 | 6 | 0.060 |
Why?
|
Drug Industry | 1 | 1985 | 46 | 0.060 |
Why?
|
Education, Medical | 1 | 1989 | 289 | 0.060 |
Why?
|
Laparotomy | 1 | 1986 | 135 | 0.060 |
Why?
|
Blood Glucose | 1 | 2009 | 1134 | 0.060 |
Why?
|
Electrocardiography | 1 | 2010 | 978 | 0.060 |
Why?
|
Zoonoses | 1 | 1984 | 44 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 856 | 0.060 |
Why?
|
Heme Oxygenase-1 | 1 | 2024 | 36 | 0.060 |
Why?
|
Orthomyxoviridae Infections | 1 | 1984 | 59 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 1987 | 443 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 1987 | 428 | 0.050 |
Why?
|
Mice, Transgenic | 2 | 2020 | 2414 | 0.050 |
Why?
|
Cell Differentiation | 2 | 2020 | 1909 | 0.050 |
Why?
|
Cell Survival | 1 | 2024 | 821 | 0.050 |
Why?
|
Ligands | 1 | 2023 | 538 | 0.050 |
Why?
|
Tamoxifen | 1 | 2023 | 363 | 0.050 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 217 | 0.050 |
Why?
|
Quality of Life | 1 | 2011 | 1908 | 0.050 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 4425 | 0.050 |
Why?
|
Swine | 1 | 1984 | 1179 | 0.040 |
Why?
|
Surveys and Questionnaires | 1 | 2011 | 3688 | 0.040 |
Why?
|
RAW 264.7 Cells | 1 | 2020 | 40 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2020 | 58 | 0.040 |
Why?
|
Mammals | 1 | 2022 | 257 | 0.040 |
Why?
|
Leucomycins | 1 | 1980 | 2 | 0.040 |
Why?
|
Urethritis | 1 | 1980 | 2 | 0.040 |
Why?
|
Gonorrhea | 1 | 1980 | 38 | 0.040 |
Why?
|
Adrenergic Agents | 1 | 2020 | 12 | 0.040 |
Why?
|
Bioreactors | 1 | 2020 | 38 | 0.040 |
Why?
|
Electric Conductivity | 1 | 2020 | 89 | 0.040 |
Why?
|
Typhoid Fever | 1 | 1979 | 20 | 0.040 |
Why?
|
Aged, 80 and over | 1 | 2011 | 6555 | 0.040 |
Why?
|
Adipogenesis | 1 | 2020 | 72 | 0.040 |
Why?
|
Tissue Scaffolds | 1 | 2020 | 80 | 0.040 |
Why?
|
Epinephrine | 1 | 2020 | 177 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2020 | 404 | 0.040 |
Why?
|
Lipids | 1 | 2022 | 519 | 0.040 |
Why?
|
Fatty Acids | 1 | 2020 | 344 | 0.040 |
Why?
|
Hypoxia | 1 | 2020 | 249 | 0.040 |
Why?
|
Tissue Engineering | 1 | 2020 | 174 | 0.040 |
Why?
|
Kinetics | 1 | 2020 | 1330 | 0.040 |
Why?
|
Rats | 1 | 2024 | 3729 | 0.040 |
Why?
|
Apoptosis | 1 | 2024 | 1818 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 364 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2024 | 3420 | 0.030 |
Why?
|
RNA | 1 | 2020 | 575 | 0.030 |
Why?
|
Efficiency, Organizational | 1 | 1997 | 54 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2022 | 765 | 0.030 |
Why?
|
Outpatient Clinics, Hospital | 1 | 1997 | 74 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 1982 | 0.030 |
Why?
|
Macrophages | 1 | 2020 | 626 | 0.030 |
Why?
|
Anti-Bacterial Agents | 2 | 1987 | 2429 | 0.030 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2015 | 18 | 0.030 |
Why?
|
Health Resources | 1 | 1997 | 116 | 0.030 |
Why?
|
Glucokinase | 1 | 2015 | 16 | 0.030 |
Why?
|
ARNTL Transcription Factors | 1 | 2015 | 39 | 0.030 |
Why?
|
Forearm | 1 | 2015 | 45 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 1997 | 309 | 0.030 |
Why?
|
Optical Imaging | 1 | 2015 | 66 | 0.030 |
Why?
|
Free Tissue Flaps | 1 | 2015 | 51 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2020 | 641 | 0.030 |
Why?
|
Nuclear Receptor Coactivator 2 | 1 | 2015 | 201 | 0.030 |
Why?
|
Cells, Cultured | 1 | 2020 | 3044 | 0.030 |
Why?
|
Inflammation | 1 | 2020 | 1446 | 0.030 |
Why?
|
United States | 5 | 1997 | 10910 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2020 | 2373 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2014 | 373 | 0.020 |
Why?
|
Skin | 1 | 2015 | 521 | 0.020 |
Why?
|
Cell Line | 1 | 2017 | 2757 | 0.020 |
Why?
|
Medicare | 2 | 1997 | 427 | 0.020 |
Why?
|
Models, Biological | 1 | 2015 | 1465 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 2057 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2014 | 474 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 1990 | 79 | 0.020 |
Why?
|
Organizational Affiliation | 1 | 1989 | 1 | 0.020 |
Why?
|
Fees, Medical | 1 | 1989 | 6 | 0.020 |
Why?
|
Health Maintenance Organizations | 1 | 1989 | 22 | 0.020 |
Why?
|
Transcription Factors | 1 | 2020 | 2603 | 0.020 |
Why?
|
Periaqueductal Gray | 1 | 1989 | 5 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2015 | 2881 | 0.020 |
Why?
|
Infection Control | 2 | 1987 | 156 | 0.020 |
Why?
|
Schools, Medical | 1 | 1989 | 110 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2014 | 605 | 0.020 |
Why?
|
History, 18th Century | 1 | 1988 | 70 | 0.020 |
Why?
|
History, 19th Century | 1 | 1988 | 117 | 0.020 |
Why?
|
Heart, Artificial | 2 | 1978 | 70 | 0.020 |
Why?
|
Eye Diseases | 1 | 1989 | 117 | 0.020 |
Why?
|
Europe | 1 | 1988 | 359 | 0.020 |
Why?
|
Clostridium perfringens | 1 | 1986 | 7 | 0.020 |
Why?
|
Fusobacterium Infections | 1 | 1986 | 14 | 0.020 |
Why?
|
Brain Diseases | 1 | 1989 | 300 | 0.020 |
Why?
|
Jugular Veins | 1 | 1986 | 76 | 0.020 |
Why?
|
Coronary Disease | 2 | 1978 | 671 | 0.010 |
Why?
|
Influenza A virus | 1 | 1984 | 139 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 1989 | 1901 | 0.010 |
Why?
|
Kidney Transplantation | 2 | 1978 | 653 | 0.010 |
Why?
|
Picornaviridae Infections | 1 | 1982 | 48 | 0.010 |
Why?
|
Heart Transplantation | 2 | 1978 | 859 | 0.010 |
Why?
|
Sepsis | 1 | 1986 | 484 | 0.010 |
Why?
|
Interferons | 1 | 1982 | 126 | 0.010 |
Why?
|
Thrombosis | 1 | 1986 | 524 | 0.010 |
Why?
|
Acute Disease | 2 | 1980 | 1097 | 0.010 |
Why?
|
Cambodia | 1 | 1979 | 11 | 0.010 |
Why?
|
Refugees | 1 | 1979 | 31 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1980 | 729 | 0.010 |
Why?
|
Assisted Circulation | 1 | 1978 | 36 | 0.010 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 1978 | 42 | 0.010 |
Why?
|
Veterans | 1 | 1989 | 1726 | 0.010 |
Why?
|
Child | 3 | 1987 | 24625 | 0.010 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1976 | 29 | 0.010 |
Why?
|
Guideline Adherence | 1 | 1997 | 375 | 0.010 |
Why?
|
Faculty, Medical | 1 | 1997 | 262 | 0.010 |
Why?
|
Practice Patterns, Physicians' | 1 | 1997 | 733 | 0.010 |
Why?
|
Transplantation, Homologous | 2 | 1978 | 621 | 0.000 |
Why?
|
Internship and Residency | 1 | 1997 | 1183 | 0.000 |
Why?
|
Mitral Valve | 2 | 1978 | 252 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1978 | 3055 | 0.000 |
Why?
|
Heart Valve Prosthesis | 2 | 1978 | 302 | 0.000 |
Why?
|
Aortic Valve | 2 | 1978 | 445 | 0.000 |
Why?
|
Drug Evaluation | 1 | 1982 | 105 | 0.000 |
Why?
|
Rhinovirus | 1 | 1982 | 59 | 0.000 |
Why?
|
Aerosols | 1 | 1982 | 65 | 0.000 |
Why?
|
Nasal Cavity | 1 | 1982 | 50 | 0.000 |
Why?
|
Contracture | 1 | 1978 | 24 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1982 | 1608 | 0.000 |
Why?
|
Muscle Contraction | 1 | 1978 | 188 | 0.000 |
Why?
|
Blood Coagulation Disorders | 1 | 1978 | 103 | 0.000 |
Why?
|
Heart Valve Diseases | 1 | 1978 | 174 | 0.000 |
Why?
|
Endocarditis, Bacterial | 1 | 1978 | 136 | 0.000 |
Why?
|
Cardiopulmonary Bypass | 1 | 1978 | 354 | 0.000 |
Why?
|
Adolescent | 2 | 1986 | 19427 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1976 | 256 | 0.000 |
Why?
|
Heart Conduction System | 1 | 1976 | 147 | 0.000 |
Why?
|
Syndrome | 1 | 1978 | 1120 | 0.000 |
Why?
|
Blood Flow Velocity | 1 | 1976 | 454 | 0.000 |
Why?
|
Heart Ventricles | 1 | 1978 | 783 | 0.000 |
Why?
|
Kidney | 1 | 1978 | 1361 | 0.000 |
Why?
|
Infant | 1 | 1986 | 12606 | 0.000 |
Why?
|
Blood Pressure | 1 | 1976 | 1351 | 0.000 |
Why?
|
Child, Preschool | 1 | 1986 | 14154 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 1976 | 1959 | 0.000 |
Why?
|